Vanash Patel, consultant colorectal and general surgeon, colorectal lead, and robotic surgery lead at WHTH. Image provided by Vanesh Patel
West Hertfordshire Teaching Hospitals NHS Trust (WHTH) is trialling a technology-enabled pathway to provide…
Continue Reading
What You Should Know:
–Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data, today announced the launch of six new hematology Panoramic datasets, representing another critical moment…
Continue Reading
Nargiz Noimann, Founder of X-Technology
Clinicians rightly celebrate when treatment ends. Yet many patients leave our clinics still carrying the invisible weight of illness—anxiety, low mood, pain, and a fragile sense of self. The evidence…
Continue Reading
Robin Shah, Co-Founder and Chief Executive Officer; Dr. Bobby Green, Co-Founder, Chief Medical Officer, and President; and Dr. Brad Diephuis, President and Chief Operating Officer
What You Should Know:
– Thyme Care, a value-based cancer care…
Continue Reading
What You Should Know:
– Daymark Health, a company dedicated to redefining the cancer care experience secures $20M in Series A funding round led by Healthier Capital and Blue Venture Fund, with continued participation from…
Continue Reading
What You Should Know:
– Leo Cancer Care, a pioneer in radiotherapy treatment devices, has successfully raised $40M in funding round led by Catalio Capital Management.
– The investment, which also saw participation from new and…
Continue Reading
Dr. Michael Morris, one of the founders of United Theranostics, whose mission is to make molecular imaging and radiopharmaceutical therapy accessible to all patients in a comfortable environment with the highest quality of care…
Continue Reading
Cancer Awareness Trust is launching a platform in the UK to support people affected by cancer, designed in partnership with digital product studio, ustwo.
The Cancer Platform will first be piloted with prostate and breast…
Telehealth has been promoted as a solution to spatial healthcare access barriers, yet its role in addressing cancer care disparities remains uncertain, particularly in the context of digital divides in broadband availability and affordability….
Continue Reading
What You Should Know:
– Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI…
Continue Reading
